Targeting Cyclic GMP-AMP Synthase: Novel Therapeutic Inhibitors for Autoimmune Diseases

Area of Science:

• Immunology
• Molecular Biology
• Drug Discovery

Background:

• Cyclic GMP-AMP synthase (cGAS) is a key sensor of intracellular DNA.
• Activation of the cGAS-STING pathway is vital for innate immunity against pathogens and tumors.
• Dysregulation of this pathway contributes to autoimmune and inflammatory diseases.

Purpose of the Study:

• To provide a comprehensive review of recent advancements in cGAS inhibitor research.
• To detail the discovery, characteristics, and efficacy of cGAS inhibitors.
• To discuss challenges and future directions in the therapeutic development of cGAS inhibitors.

Main Methods:

• Literature review of recent studies on cGAS inhibitors.
• Analysis of inhibitor discovery, structural features, and mechanisms of action.
• Evaluation of structure-activity relationships and preclinical data.

Main Results:

• Numerous potent and specific cGAS inhibitors have been developed.
• Inhibitors exhibit diverse structural characteristics and mechanisms of action.
• Preclinical studies demonstrate promising efficacy, but challenges like species specificity remain.

Conclusions:

• cGAS inhibitors represent a significant therapeutic opportunity for autoimmune and inflammatory conditions.
• Further research is needed to overcome existing challenges and advance clinical translation.
• Targeting the cGAS-STING pathway holds potential for treating various diseases.